Claraphi Advisory Network, LLC Exact Sciences Corp Transaction History

Claraphi Advisory Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $188,962 - $259,760	-2,094 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $204,459 - $304,026	-2,183 Reduced 51.04%	2,094 $260,000
Q1 2021 Apr 30, 2021	BUY	$116.57 - $155.01 $498,569 - $662,977	4,277 New	4,277 $564,000
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $77,492 - $128,922	-1,390 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $52,681 - $145,171	1,390 New	1,390 $81,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.